M14-237
ClinicalTrials.gov NCT02099058
Research payments
$433,430
Through program year 2020, $433,430 in research payments was reported against M14-237, across 106 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT02099058
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $112,657 | 31 |
| 2019 | Research | $320,773 | 75 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Camidge Munich, CO Named on 20 payments
- Todd Bauer Nashville, TN Named on 14 payments
- Minal Barve Dallas, TX Named on 12 payments
- Gordon Srkalovic Lansing, MI Named on 11 payments
- Alexander Spira Fairfax, VA Named on 9 payments
- Daniel Morgensztern Saint Louis, MO Named on 7 payments
- Rebecca Heist Boston, MA Named on 4 payments
- Jonathan Goldman Santa Monica, CA Named on 4 payments
- John Strickler Durham, NC Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.